 |
Articles: Pharmacoeconomics |
The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan
Cost Effectiveness and Resource Allocation, 11/04/09
Free full text
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents. A Cost-Effectiveness Analysis
Annals of Internal Medicine, 11/03/09 Cost-effectiveness of interventions based on physical exercise in the treatment of various diseases
International Journal of Technology Assessment in Health Care, 11/02/09 Incidence and economic burden of suspected adverse events and adverse event monitoring during AF therapy
Current Medical Research and Opinion, 10/30/09 Investment in antiviral drugs: a real options approach
Health Economics, 10/29/09 Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report-Part V
Value in Health, 10/29/09 Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI
Value in Health, 10/29/09 Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report-Part III
Value in Health, 10/29/09 The possible macroeconomic impact on the UK of an influenza pandemic
Health Economics, 10/29/09 A simple cost-effective high performance liquid chromatographic assay of sulphadoxine in whole blood spotted on filter paper for field studies
Malaria Journal, 10/27/09
Free full text
Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia
Cost Effectiveness and Resource Allocation, 10/22/09
Free full text
Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China
Hepatology, 10/20/09 Use and cost of branded and generic drugs in patients with coronary heart disease-results from a prospective survey of 1008 patients in two London hospitals
QJM: An International Journal of Medicine, 10/16/09 Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting
Clinical Drug Investigation, 10/15/09
Revew Article
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
Clinical Pharmacokinetics, 10/15/09 30 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement
PharmacoEconomics, 10/13/09 Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide
PharmacoEconomics, 10/13/09 An Economic Evaluation of Docetaxel and Paclitaxel Regimens in Metastatic Breast Cancer in the UK
PharmacoEconomics, 10/12/09 Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed
Current Medical Research and Opinion, 10/09/09 Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology
Journal of Pharmacology and Experimental Therapeutics, 10/08/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
151 Available Pages
|
|
